63 related articles for article (PubMed ID: 32895212)
1. [Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer].
Yao W; Lu N; Cui M; Wang J; Du Z; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):837-842. PubMed ID: 32895212
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.
Cheraghlou S; Agogo GO; Girardi M
JAMA Dermatol; 2019 Jul; 155(7):803-811. PubMed ID: 30825411
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
Wang J; Liu F; Ma W; Hu H; Li F
Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.
Luo Z; Hei H; Qin J; Zheng C; Gong W; Zhou B
Langenbecks Arch Surg; 2023 Aug; 408(1):315. PubMed ID: 37584830
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.
Zhang X; Feng N; Wu B; Wei Y; Zhang W
Medicine (Baltimore); 2023 Oct; 102(40):e35341. PubMed ID: 37800757
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.
Zhang Y; Cao Y; Zhang J; Huang M; Roy P; Huang B; Yang H; Rong Y; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Lin J; Zhang J; Fu J; He J; Li H
Ann Surg; 2023 Jun; 277(6):e1239-e1246. PubMed ID: 35797545
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.
Chen P; Wang L; Yang X; Feng J
Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214
[TBL] [Abstract][Full Text] [Related]
8. Positive lymph node ratio is an important index to predict long-term survival for advanced esophageal squamous carcinoma patients (II∼III) with R0 resection--a SEER-based analysis.
Hou B; Yuan J; Kang S; Yang Y; Huang X; Xu H; Guo K; Tian W
Heliyon; 2023 Dec; 9(12):e22600. PubMed ID: 38144311
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor deposits and positive lymph node ratio in stage III colorectal cancer: a retrospective cohort study.
Liu L; Ji J; Ge X; Ji Z; Li J; Wu J; Zhu J; Yao J; Zhu F; Mao B; Cao Z; Zhou J; Miao L; Ji G; Hang D
Int J Surg; 2024 Mar; ():. PubMed ID: 38498367
[TBL] [Abstract][Full Text] [Related]
10. Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study.
Prinzi A; Frasca F; Russo M; Le Moli R; Belfiore A; Malandrino P
Endocr Pract; 2024 Mar; 30(3):194-199. PubMed ID: 38008257
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Diagnosis for Breast Cancer Patients Using Probabilistic Bayesian Classification.
Junath N; Bharadwaj A; Tyagi S; Sengar K; Hasan MNS; Jayasudha M
Biomed Res Int; 2022; 2022():1859222. PubMed ID: 35924264
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Significance of Lymph Node Ratio for Esophageal Cancer: A Meta-Analysis.
Song J; Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
J Surg Res; 2023 Dec; 292():53-64. PubMed ID: 37586187
[TBL] [Abstract][Full Text] [Related]
13. [Progress in correlation between lymph node metastasis and prognosis of esophageal cancer].
Fu L; Mao YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):84-91. PubMed ID: 38262906
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.
Yan S; Liu X; Xing W; Jiang D; Feng SK; Chang AC; Sun HB
Dis Esophagus; 2024 Jan; 37(1):. PubMed ID: 37455547
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical features and prognostic factors of lung cancer patients: A population-based cohort study.
Gao Y; Zhou X
Clin Respir J; 2020 Aug; 14(8):712-724. PubMed ID: 32191390
[TBL] [Abstract][Full Text] [Related]
16. Expression of PTP4A1 in circulating tumor cells and its efficacy evaluation in patients with early- and intermediate-stage esophageal cancer.
Wu J; Wang WX; Zhou Y; Yang DS; Wu ZN; Li X; Tang JM
Medicine (Baltimore); 2023 Dec; 102(51):e36603. PubMed ID: 38134119
[TBL] [Abstract][Full Text] [Related]
17. Comparison of survival between diffuse type and intestinal type early-onset gastric cancer patients: A large population-based study.
Wang Q; Wang T
Medicine (Baltimore); 2023 Nov; 102(47):e36261. PubMed ID: 38013337
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract][Full Text] [Related]
19. The impact of indirect notification of a cancer diagnosis and a risk model based on it to predict the prognosis of postoperative stage T3 esophageal cancer patients.
Cheng Y; Yu M; Yao Q; He T; Zhang R; Long Z
Medicine (Baltimore); 2023 Nov; 102(44):e35895. PubMed ID: 37932980
[TBL] [Abstract][Full Text] [Related]
20. The different routes of lymph node metastases in esophageal cancer and its significance.
Hutchings H; Okereke IC
J Thorac Dis; 2023 Nov; 15(11):5873-5876. PubMed ID: 38090311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
